Preferred Label : xolair;
UMLS semantic type : T121 - Pharmacologic Substance; T129 - Immunologic Factor;
Is substance : O;
Origin ID : M0446701;
UMLS CUI : C1174773;
Related record
- Semantic type(s)
https://www.has-sante.fr/jcms/p_3487904/fr/xolair-omalizumab-polypose-naso-sinusienne
2024
false
false
false
France
nasal polyps
Polyp of nasal cavity and/or nasal sinus (disorder)
evaluation of the transparency committee
xolair
Omalizumab
Polyposis
Omalizumab
---
https://www.has-sante.fr/jcms/p_3473151/fr/dupixent-fasenra-nucala-tezspire-et-xolair-dans-le-traitement-de-l-asthme-severe
2023
France
guidelines for drug use
No Treatment for Diabetes
Nucala
Omalizumab
Borg Category-Ratio 10 Perceived Exertion Score 5
Omalizumab
Treat
tezspire
Treatment
Treatment Study
Severe Hallucination
Intensity and Distress 5
Severe Adverse Event
During Treatment
Epidermal cGVHD Score 4
Asthma
Dupilumab
asthma
Fasenra
Asthma Pathway
xolair
severe
Severe Dysplasia
asthma, nos
On Treatment
GDC Treatment Frequency Terminology
Treatment Epoch
Therapy Object
Dupixent
asthma
Biomaterial Treatment
Severe Extremity Pain
Mepolizumab
---
https://www.has-sante.fr/jcms/p_3182802
2020
France
evaluation of the transparency committee
Omalizumab
xolair
---
https://www.has-sante.fr/portail/jcms/c_2788633/fr/xolair
2017
false
false
false
France
French
evaluation of the transparency committee
xolair
Omalizumab
---
